Literature DB >> 7277212

An aid to decision-making in bioequivalence assessment.

H Fluehler, J Hirtz, H A Moser.   

Abstract

Mesh：

Year:  1981        PMID： 7277212     DOI： 10.1007/BF01068085

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  3 in total

1.  Symmetrical confidence intervals for bioequivalence trials.

Authors:  W J Westlake
Journal:  Biometrics       Date:  1976-12       Impact factor: 2.571

2.  Use of confidence intervals in analysis of comparative bioavailability trials.

Authors:  W J Westlake
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

3.  Comparison of different methods for decision-making in bioequivalence assessment.

Authors:  D Mandallaz; J Mau
Journal:  Biometrics       Date:  1981-06       Impact factor: 2.571
  3 in total
  9 in total

1.  Population characteristics of biological systems influenced by multicomponent random and uniform variation.

Authors:  G M Kochak
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

2.  The bioavailability of three altretamine formulations.

Authors:  E A Runhaar; J P Neijt; J J Holthuis; D de Vos
Journal:  Pharm Weekbl Sci       Date:  1989-12-15

3.  Assessment of variance in bioavailability studies: comments on the article by McNamara et al.

Authors:  C M Metzler
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

4.  Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers.

Authors:  I De Lepeleire; A Van Hecken; R Verbesselt; G Kaiser; A Barner; I Holmes; P J De Schepper
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Generalization of distribution--free confidence intervals for bioavailability ratios.

Authors:  V W Steinijans; E Diletti
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Absolute bioavailability of mianserin tablets and solution in healthy humans.

Authors:  C J Timmer; S Pourbaix; J P Desager; M Sclavons; C Harvengt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

7.  Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals.

Authors:  V W Steinijans; E Diletti
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  The bioavailability of Tamoplex (tamoxifen). Part 3. A steady-state study in breast cancer patients.

Authors:  P H Slee; D De Vos; D Chapman; D Stevenson
Journal:  Pharm Weekbl Sci       Date:  1988-02-19

9.  Comparative bioavailability study of two haloperidol decanoate containing products.

Authors:  G van Weringh; B J Komen; R E Thieme; R T van der Hoeven; T Vos
Journal:  Pharm World Sci       Date:  1994-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.